| 1 | = | Malignant Prostate Neoplasm | 249,205 | 100 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 8351
- siteDefinition
- USCS "Prostate" (ICD-10 C61; ICD-O-3 C619)
ranking row 2604420 |
| 2 | = | Malignant Lung Neoplasm | 119,080 | 96.2 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 3811
- siteDefinition
- USCS "Lung and Bronchus" (ICD-10 C34; ICD-O-3 C340-C349)
ranking row 2604421 |
| 3 | = | Malignant Bladder Neoplasm | 60,935 | 92.3 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 7381
- siteDefinition
- USCS "Urinary Bladder" (ICD-10 C67; ICD-O-3 C670-C679)
ranking row 2604422 |
| 4 | = | Cutaneous Melanoma | 55,835 | 88.5 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4117
- siteDefinition
- USCS "Melanomas of the Skin" (ICD-10 C43; ICD-O-3 C440-C449 with histology 8720-8790)
ranking row 2604423 |
| 5 | = | Malignant Colon Neoplasm | 53,394 | 84.6 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 907
- siteDefinition
- USCS "Colon excluding Rectum" (ICD-10 C18, C26.0; ICD-O-3 C180-C189, C260)
ranking row 2604424 |
| 6 | = | Malignant Kidney Neoplasm | 46,898 | 80.8 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2587
- siteDefinition
- USCS "Kidney and Renal Pelvis" (ICD-10 C64-C65; ICD-O-3 C649, C659)
ranking row 2604425 |
| 7 | = | Non-Hodgkin Lymphoma | 42,683 | 76.9 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 5341
- siteDefinition
- USCS "Non-Hodgkin Lymphoma" (ICD-10 C82-C85, C96.3; ICD-O-3 histology 9590-9597, 9670-9729, 9735, 9737-9738 (+9811-9818, 9823, 9827, 9837 outside marrow/blood))
ranking row 2604426 |
| 8 | = | Leukemia | 33,778 | 73.1 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 3199
- siteDefinition
- USCS "Leukemias" (ICD-10 C91-C95 (leukemia recodes; C90.1 plasma cell leukemia included by SEER); ICD-O-3 leukemia histologies 9733-9948 per SEER site recode)
ranking row 2604427 |
| 9 | = | Malignant Pancreatic Neoplasm | 29,523 | 69.2 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 5851
- siteDefinition
- USCS "Pancreas" (ICD-10 C25; ICD-O-3 C250-C259)
ranking row 2604428 |
| 10 | = | Malignant Liver Neoplasm | 27,136 | 65.4 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 3505
- siteDefinition
- USCS "Liver and Intrahepatic Bile Duct" (ICD-10 C22; ICD-O-3 C220-C221)
ranking row 2604429 |
| 11 | = | Malignant Rectal Neoplasm | 26,303 | 61.5 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6157
- siteDefinition
- USCS "Rectum and Rectosigmoid Junction" (ICD-10 C19-C20; ICD-O-3 C199, C209)
ranking row 2604430 |
| 12 | = | Multiple Myeloma | 17,201 | 57.7 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4729
- siteDefinition
- USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734)
ranking row 2604431 |
| 13 | = | Malignant Gastric Neoplasm | 15,695 | 53.8 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6769
- siteDefinition
- USCS "Stomach" (ICD-10 C16; ICD-O-3 C160-C169)
ranking row 2604432 |
| 14 | = | Malignant Esophageal Neoplasm | 15,636 | 50 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 1417
- siteDefinition
- USCS "Esophagus" (ICD-10 C15; ICD-O-3 C150-C159)
ranking row 2604433 |
| 15 | = | Malignant Central Nervous System Neoplasm | 13,455 | 46.2 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 397
- siteDefinition
- USCS "Brain and Other Nervous System" (ICD-10 C70, C71, C72; ICD-O-3 C700-C709, C710-C719, C720-C729)
ranking row 2604434 |
| 16 | = | Malignant Thyroid Gland Neoplasm | 13,162 | 42.3 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 7075
- siteDefinition
- USCS "Thyroid" (ICD-10 C73; ICD-O-3 C739)
ranking row 2604435 |
| 17 | = | Malignant Laryngeal Neoplasm | 10,230 | 38.5 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2893
- siteDefinition
- USCS "Larynx" (ICD-10 C32; ICD-O-3 C320-C329)
ranking row 2604436 |
| 18 | = | Malignant Testicular Neoplasm | 9,310 | 34.6 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 8555
- siteDefinition
- USCS "Testis" (ICD-10 C62; ICD-O-3 C620-C629)
ranking row 2604437 |
| 19 | = | Hodgkin Lymphoma | 4,986 | 30.8 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 1825
- siteDefinition
- USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal))
ranking row 2604438 |
| 20 | = | Malignant Salivary Gland Neoplasm | 3,099 | 26.9 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6463
- siteDefinition
- USCS "Salivary Gland" (ICD-10 C07-C08; ICD-O-3 C079-C089)
ranking row 2604439 |
| 21 | = | Malignant Anal Neoplasm | 2,942 | 23.1 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 91
- siteDefinition
- USCS "Anus, Anal Canal and Anorectum" (ICD-10 C21; ICD-O-3 C210-C212, C218)
ranking row 2604440 |
| 22 | = | Malignant Breast Neoplasm | 2,392 | 19.2 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 8045
- siteDefinition
- USCS "Male Breast" (ICD-10 C50; ICD-O-3 C500-C509)
ranking row 2604441 |
| 23 | = | Malignant Mesothelioma | 2,283 | 15.4 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4423
- siteDefinition
- USCS "Mesothelioma" (ICD-10 C45; ICD-O-3 histology 9050-9055 (any site))
ranking row 2604442 |
| 24 | = | Malignant Hypopharyngeal Neoplasm | 1,861 | 11.5 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2131
- siteDefinition
- USCS "Hypopharynx" (ICD-10 C12-C13; ICD-O-3 C129, C130-C139)
ranking row 2604443 |
| 25 | = | Malignant Penile Neoplasm | 1,615 | 7.7 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 8147
- siteDefinition
- USCS "Penis" (ICD-10 C60; ICD-O-3 C600-C609)
ranking row 2604444 |
| 26 | = | Malignant Nasopharyngeal Neoplasm | 1,379 | 3.8 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 5035
- siteDefinition
- USCS "Nasopharynx" (ICD-10 C11; ICD-O-3 C110-C119)
ranking row 2604445 |
| 27 | = | Kaposi Sarcoma | 978 | 0 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2437
- siteDefinition
- USCS "Kaposi Sarcoma" (ICD-10 C46; ICD-O-3 histology 9140 (any site))
ranking row 2604446 |